About the Product

Description


Cholzide C Tablet containing Chlordiazepoxide and Clidinium is used for the management of gastrointestinal disorders associated with abdominal cramps, intestinal spasms, and anxiety-related digestive symptoms. It helps improve digestive comfort and overall gastrointestinal well-being.

Chlordiazepoxide helps reduce anxiety and tension that may contribute to gastrointestinal discomfort, while Clidinium acts as an antispasmodic agent that helps relax smooth muscles of the digestive tract and reduce spasms.

The tablet is widely prescribed in gastroenterology and general medicine practice for functional gastrointestinal disorders and related digestive complaints, leading to consistent prescription demand.

With the increasing prevalence of digestive health concerns and growing demand for effective gastrointestinal therapies, this product offers strong business potential for retailers and distributors. Its combination formulation, established clinical relevance, and steady market demand make it a reliable product for growth in the gastrointestinal care segment.

Important Notice: Chlordiazepoxide is a prescription medicine that may be subject to specific regulatory and dispensing requirements. Distribution and marketing should comply with all applicable regulations.

Some patients may experience drowsiness, dizziness, dry mouth, blurred vision, constipation, nausea, fatigue, or difficulty concentrating. Rarely, confusion, urinary retention, dependence with prolonged use, severe allergic reactions, or paradoxical agitation may occur and require immediate medical attention.

Cholzide C Tablet is indicated for irritable bowel syndrome (IBS), gastrointestinal spasms, functional gastrointestinal disorders, peptic ulcer-associated discomfort, abdominal cramps, and anxiety-related digestive symptoms. It helps reduce abdominal pain, bloating, cramping, and digestive discomfort.

This medicine should be used strictly under medical supervision. Chlordiazepoxide may cause drowsiness and has the potential for dependence with prolonged use. Avoid alcohol and activities requiring mental alertness, such as driving or operating machinery. Use cautiously in patients with glaucoma, prostate enlargement, liver disease, kidney impairment, or respiratory disorders.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Chlordiazepoxide 5mg + Clidinium 2.5mg Tablet in the PCD pharma franchise market?

Chlordiazepoxide 5mg + Clidinium 2.5mg Tablet has strong demand in the gastroenterology, gastrointestinal care, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on digestive health and GI care portfolios.

Why should medical distributors include Chlordiazepoxide + Clidinium Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for gastrointestinal disorder management under medical supervision. Chlordiazepoxide 5mg helps reduce anxiety and tension that may contribute to gastrointestinal discomfort Clidinium 2.5mg is an antispasmodic agent that helps reduce stomach and intestinal spasms Commonly prescribed for irritable bowel syndrome (IBS), peptic ulcer-associated symptoms, abdominal cramps, and functional gastrointestinal disorders Helps provide relief from abdominal pain, bloating, and digestive discomfort This strengthens a comprehensive gastroenterology and digestive care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Chlordiazepoxide 5mg + Clidinium 2.5mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from steady prescription demand in gastroenterology and general medicine practice, repeat therapy usage, reliable supply chain support, strong market acceptance, and attractive margins in the gastrointestinal care segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.